WASHINGTON D.C. CONSORTIUM PEDIATRIC AIDS CLINICAL TRIAL
WASHINGTON D.C. CONSORTIUM PEDIATRIC AIDS CLINICAL TRIAL
批准号:
6415846
负责人:
Hans M Spiegel
金额:
$91.78万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-03-01 至 2003-02-28
关键词:
2'3' dideoxycytidine 2'3' dideoxyinosine AIDS AIDS /HIV test AIDS education /prevention AIDS vaccines Epstein Barr virus Mycobacterium avium Pneumocystis carinii Pneumocystis pneumonia Streptococcus pneumoniae vaccine adolescence (12-20) antiviral agents antiviral antibody atovaquone behavioral /social science research tag chemoprevention child (0-11) clinical research clinical trial phase I combination chemotherapy community congenital infection cooperative study cytomegalovirus dapsone data management drug administration routes epidemiology family ganciclovir health behavior human immunodeficiency virus 1 human pregnant subject human subject immunotherapy measles vaccine microorganism disease chemotherapy monoclonal antibody nervous system infection neuropsychological tests nevirapine opportunistic infections outcomes research passive immunization pathologic process pediatric AIDS pharmacokinetics phenotype polymerase chain reaction premature infant human protease inhibitor retinitis stavudine tissue /cell culture vertical transmission virus DNA virus RNA virus infection mechanism virus related neoplasm /cancer zidovudine
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Washington DC Regional Pediatric AIDS Clinical Research Unit
(PACTU) will function as a member of the Pediatric AIDS Treatment Group
(PACTG) with the Coordinating and Operations Center (CORC) --Spector.
The Goals and Specific Aims of the PACTU are the same as those
identified in the Scientific Agenda of the PACTG--CORC and in the RFA.
The three primary goals are (1) to decrease mother-to-infant
transmission of HIV to less than 2%; (2) to achieve a 90% 10 year
survival for children perinatally infected with HIV and (3) to develop
novel strategies for early treatment Of newly infected infants and
adolescents. The PACTU will conduct Phase I, II and Ill clinical
studies with the PACTG. The PACTU has available a significant number
of HIV infected patients for possible study. Each year there are 50 new
pregnant women, 40 new children and 20 new adolescents and young
adults. The PACTU also follows 245 children and 85 adolescents and
young adults who are potential candidates for studies.. The PACTU has
four years of experience with Phase I, II and II, ACTG studies
involving perinatal transmission, primary therapy, opportunistic
infections, immune based therapy and long-term follow-up. Accrual has
always been above target and the quality of data has been excellent.
The PACTU is particularly active in studies to reduce perinatal
transmission and has submitted concept sheets and capsules to the ACTG
and has conducted supplemental investigations in this area of research.
Members of the PACTU serve in leadership positions of the PACTG. The
PACTU supports the Scientific Agenda of the CORC by participating in
developing, monitoring and revising the Scientific Agenda; serving in
leadership positions on the RACs and Committees; submitting capsules
and concept sheets for clinical and more fundamental studies;
conducting the research protocols of the RACs and Committees; serving
on protocol teams; conducting supplemental investigations; and
participating in the reporting of results through meetings and
scientific publications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ACTG 219C: PEDIATRIC LATE OUTCOME PROTOCOL, VERSION 30 HIV/AIDS
-
批准号:7717147
-
项目类别:
-
资助金额:$5.65万
-
财政年份:2007
-
负责人:Hans M Spiegel
-
依托单位:
ACTG 219C: PEDIATRIC LATE OUTCOME PROTOCOL, VERSION 30 HIV/AIDS
-
批准号:7608334
-
项目类别:
-
资助金额:$1.42万
-
财政年份:2006
-
负责人:Hans M Spiegel
-
依托单位:
ACTG 219C: PEDIATRIC LATE OUTCOME PROTOCOL, VERSION 40
-
批准号:7376168
-
项目类别:
-
资助金额:$0.27万
-
财政年份:2005
-
负责人:Hans M Spiegel
-
依托单位:
PACTG 1045: MORPHOLOGIC & METABOLIC ABNORMALITY IN HIV-INFECT & UNINFECT CHILD
-
批准号:7199767
-
项目类别:
-
资助金额:$0.49万
-
财政年份:2005
-
负责人:Hans M Spiegel
-
依托单位:
PACTG P1006: THE EFFECTS OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART)
-
批准号:7376171
-
项目类别:
-
资助金额:$0.14万
-
财政年份:2005
-
负责人:Hans M Spiegel
-
依托单位:
PACTG P1006: THE EFFECTS OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART)
-
批准号:7199762
-
项目类别:
-
资助金额:$0.36万
-
财政年份:2005
-
负责人:Hans M Spiegel
-
依托单位:
PACTG 1010: ANTIRETROVIRAL THERAPY ON BODY COMPOSITION
-
批准号:7199763
-
项目类别:
-
资助金额:$0.24万
-
财政年份:2005
-
负责人:Hans M Spiegel
-
依托单位:
PACTG 351 PHASE 1/11TRIAL OF CD4-1GG2 HIV-INFECTED CHIL
-
批准号:7199766
-
项目类别:
-
资助金额:$0.13万
-
财政年份:2005
-
负责人:Hans M Spiegel
-
依托单位:
HIV SPECIFIC IMMUNE RESPONSES AND DISEASE PROGRESSION IN PEDIATRIC HIV-1 INFECTI
-
批准号:7376206
-
项目类别:
-
资助金额:$0.14万
-
财政年份:2005
-
负责人:Hans M Spiegel
-
依托单位:
ACTG 219C: PEDIATRIC LATE OUTCOMES PROTOCOL, VERSION 40
-
批准号:7199761
-
项目类别:
-
资助金额:$0.98万
-
财政年份:2005
-
负责人:Hans M Spiegel
-
依托单位:
P1025: PERINATAL CORE PROTOCOL, VERSION 20
-
批准号:7199764
-
项目类别:
-
资助金额:$0.65万
-
财政年份:2005
-
负责人:Hans M Spiegel
-
依托单位:
PACTG 1030: PHASE I/II STUDY OF LOPINAVIR/RITONAVIR IN
-
批准号:7199765
-
项目类别:
-
资助金额:$0.44万
-
财政年份:2005
-
负责人:Hans M Spiegel
-
依托单位:
P1030: A PHASE I/II STUDY OF LOPINAVIR/RITONAVIR IN HIV-1 INFECTED INFANTS < 6
-
批准号:7376191
-
项目类别:
-
资助金额:$0.27万
-
财政年份:2005
-
负责人:Hans M Spiegel
-
依托单位:
WASHINGTON D.C. CONSORTIUM PEDIATRIC AIDS CLINICAL TRIAL
-
批准号:6585713
-
项目类别:
-
资助金额:$28.41万
-
财政年份:1997
-
负责人:Hans M Spiegel
-
依托单位:
海外基金